Stock data
Co-Diagnostics, Inc. (CODX)
Co-Diagnostics, Inc. (CODX) reported revenue of US$0.62M and net income of -US$46.90M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.62M | US$0.40M | -US$50.17M | -US$46.90M | — |
| 2024 | US$3.92M | US$2.92M | -US$40.08M | -US$37.64M | — |
| 2023 | US$6.81M | US$2.63M | -US$42.71M | -US$35.33M | — |
| 2022 | US$34.22M | US$28.74M | -US$26.98M | -US$14.24M | — |
| 2021 | US$97.89M | US$86.31M | US$46.06M | US$36.66M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.17M | -US$6.28M | — |
| 2026-03-31 | US$0.15M | -US$9.14M | — |
| 2025-12-31 | US$0.26M | -US$25.75M | — |
| 2025-09-30 | US$0.15M | -US$5.89M | — |
| 2025-06-30 | US$0.16M | -US$7.73M | — |
| 2025-03-31 | US$0.05M | -US$7.53M | — |
| 2024-12-31 | US$0.15M | -US$11.03M | — |
| 2024-09-30 | US$0.64M | -US$9.70M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.